FBT
TEVA icon

Founders Bank & Trust’s Teva Pharmaceuticals TEVA Stock Holding History

Founders Bank & Trust’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$12K Hold
200
– – 0.01% 288
2014
Q3 		$11K Hold
200
– – 0.01% 287
2014
Q2 		$10K Hold
200
– – 0.01% 292
2014
Q1 		$11K Hold
200
– – 0.01% 287
2013
Q4 		$9K Hold
200
– – 0.01% 318
2013
Q3 		$8K Hold
200
– – ﹤0.01% 283
2013
Q2 		$8K Buy
+200
New +$7.79K ﹤0.01% 272

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Founders Bank & Trust's TEVA Position: Q4 2014 in Review

Founders Bank & Trust held its Teva Pharmaceuticals (TEVA) position steady in Q4 2014 at 200 shares worth $12K. The position accounts for 0.01% of the portfolio, ranked #288.

Founders Bank & Trust first reported a position in TEVA in Q2 2013 and has held it in 7 quarters since. 822 funds tracked by Wall St. Rank hold TEVA as of Q4 2014.

  • Founders Bank & Trust held 200 shares of Teva Pharmaceuticals worth $12K as of Q4 2014.
  • Founders Bank & Trust left its Teva Pharmaceuticals share count unchanged in Q4 2014.
  • Teva Pharmaceuticals made up 0.01% of Founders Bank & Trust's portfolio in Q4 2014, its #288 holding.
  • Founders Bank & Trust first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 7 quarters since.
  • 822 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2014.

Based on Founders Bank & Trust's 13F filing for Q4 2014, filed 9 Feb 2015.